Infective Endocarditis Secondary to Injection Drug Use: A Survey of Canadian Cardiac Surgeons.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
11 2021
Historique:
received: 04 09 2020
revised: 10 11 2020
accepted: 02 12 2020
pubmed: 29 12 2020
medline: 24 11 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Injection drug use-associated infective endocarditis (IDU-IE) is a growing epidemic. The objective of this survey was to identify the beliefs and practice patterns of Canadian cardiac surgeons regarding surgical management of IDU-IE. A 30-question survey was developed by a working group and distributed to all practicing adult cardiac surgeons in Canada. Data were analyzed using descriptive statistics. Of 146 surgeons, 94 completed the survey (64%). Half of surgeons (49%) would be less likely to operate on patients with IE if associated with IDU. In the case of prosthetic valve IE owing to continued IDU, 36% were willing to reoperate once and 14% were willing to reoperate twice or more. Most surgeons required commitments from patients before surgery (73%), and most referred patients to addiction services (81%). Some surgeons would offer a Ross procedure (10%) or homograft (8%) for aortic valve IE, and 47% would consider temporary mechanical circulatory support. Whereas only 17% of surgeons worked at an institution with an endocarditis team, 71% agreed that there was a need for one at each institution. Most surgeons supported the development of IDU-IE-specific guidelines (80%). Practice patterns and surgical management of IDU-IE vary considerably across Canada. Areas of clinical unmet needs include the development of a formal addiction services referral protocol for patients, the development of an interdisciplinary endocarditis team, as well as the creation of IDU-IE clinical practice guidelines.

Sections du résumé

BACKGROUND
Injection drug use-associated infective endocarditis (IDU-IE) is a growing epidemic. The objective of this survey was to identify the beliefs and practice patterns of Canadian cardiac surgeons regarding surgical management of IDU-IE.
METHODS
A 30-question survey was developed by a working group and distributed to all practicing adult cardiac surgeons in Canada. Data were analyzed using descriptive statistics.
RESULTS
Of 146 surgeons, 94 completed the survey (64%). Half of surgeons (49%) would be less likely to operate on patients with IE if associated with IDU. In the case of prosthetic valve IE owing to continued IDU, 36% were willing to reoperate once and 14% were willing to reoperate twice or more. Most surgeons required commitments from patients before surgery (73%), and most referred patients to addiction services (81%). Some surgeons would offer a Ross procedure (10%) or homograft (8%) for aortic valve IE, and 47% would consider temporary mechanical circulatory support. Whereas only 17% of surgeons worked at an institution with an endocarditis team, 71% agreed that there was a need for one at each institution. Most surgeons supported the development of IDU-IE-specific guidelines (80%).
CONCLUSIONS
Practice patterns and surgical management of IDU-IE vary considerably across Canada. Areas of clinical unmet needs include the development of a formal addiction services referral protocol for patients, the development of an interdisciplinary endocarditis team, as well as the creation of IDU-IE clinical practice guidelines.

Identifiants

pubmed: 33358887
pii: S0003-4975(20)32130-5
doi: 10.1016/j.athoracsur.2020.12.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1460-1467

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Kevin R An (KR)

Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Canada.

Jessica G Y Luc (JGY)

Division of Cardiovascular Surgery, University of British Columbia, Vancouver, Canada.

Derrick Y Tam (DY)

Division of Cardiovascular Surgery, University of British Columbia, Vancouver, Canada.

Olina Dagher (O)

Division of Cardiac Surgery, University of Calgary, Calgary, Canada.

Rachel Eikelboom (R)

Section of Cardiac Surgery, Department of Surgery, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.

Joel Bierer (J)

Division of Cardiac Surgery, Dalhousie University, Halifax, Canada.

Andréanne Cartier (A)

University of Laval Faculty of Medicine, Quebec City, Canada.

Thin X Vo (TX)

Division of Cardiac Surgery, University of Ottawa Heart Institute, University of Ottawa, Ottawa, Canada.

Olivier Vaillancourt (O)

Division of Cardiac Surgery, McGill University, Montreal, Canada.

Keir Forgie (K)

Division of Cardiac Surgery, University of Alberta, Edmonton, Canada.

Malak Elbatarny (M)

Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Canada.

Sophie Weiwei Gao (SW)

Division of Cardiac Surgery, McMaster University, Hamilton, Canada.

Richard Whitlock (R)

Division of Cardiac Surgery, McMaster University, Hamilton, Canada.

Wiplove Lamba (W)

Division of Psychiatry, St. Michael's Hospital, University of Toronto, Toronto, Canada.

Rakesh C Arora (RC)

Section of Cardiac Surgery, Department of Surgery, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.

Corey Adams (C)

Division of Cardiac Surgery, University of Calgary, Calgary, Canada.

Bobby Yanagawa (B)

Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Canada. Electronic address: yanagawab@smh.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH